M4MM

Analysis: Wall Street Quietly Tests the Water In Cannabis

NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...

Bioxyne Double-Strikes in LATAM and Europe

SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...

Rubicon Organics Reports Q1 2026 Financial Results

VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...

Glass House Brands Reports Q1 2026 Financial Results

LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...

Subscribe To Our Newsletter